The Fleming Fund's Phase I Report is now available.
The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.
We support low- and middle-income countries to generate, share and use data to improve antimicrobial use and encourage investment in AMR.
News
IVI-led CAPTURA consortium releases first country report on AMR data in Bangladesh
Date: 20/06/2023
Report contains key findings for stakeholders engaging in AMR surveillance, research, policy, regulatory decision-making, and other…
Stories
Microbiology laboratory services added to five AMR referral hospitals in Timor-Leste
Date: 26/05/2023
Fleming Fund grantee, Menzies School of Health Research boosts healthcare in Timor-Leste by successfully implementing microbiology…
Programme Update
Putting Gender and Equity at the heart of the Fleming Fund's next phase
Date: 24/03/2023
There is a growing recognition that both sex (the physical dimension) and gender (the psychosocial dimension) – and the interaction betwe…
Following the Burnet Institute’s presentation at the Royal Zoological Society of New South Wales, we speak to Programme Director Profess…
Aquaculture is the controlled cultivation of aquatic organisms used to support the growing demand for fish products. This demand, however,…
22
Active Country Grants
155
Countries have supplied data on use of antimicrobial medicines in animals to WOAH database
170
National Action Plans developed with Fleming Fund support
11
Active Regional Grants